Effects of recombinant activins on steroidogenesis in human granulosa-lutein cells

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 10, 2014, Pages E1922-E1932

  Chang, Hsun Ming ^a   Cheng, Jung Chien ^a   Klausen, Christian ^a   Taylor, Elizabeth L ^a   Leung, Peter C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN A; ACTIVIN AB; ACTIVIN AC; AROMATASE; ESTRADIOL; FOLLITROPIN RECEPTOR; GONADOTROPIN; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; MYELOPID; PROGESTERONE; RECOMBINANT PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN; UNCLASSIFIED DRUG; CYP19A1 PROTEIN, HUMAN; INHBB PROTEIN, HUMAN; INHBC PROTEIN, HUMAN; INHBE PROTEIN, HUMAN; INHIBIN; INHIBIN BETA A SUBUNIT; PHOSPHOPROTEIN;

ARTICLE; ENZYME IMMUNOASSAY; ESTROGEN SYNTHESIS; FEMALE; FERTILIZATION IN VITRO; GENE EXPRESSION REGULATION; GRANULOSA CELL; HORMONAL REGULATION; HUMAN; HUMAN CELL; LUTEAL CELL; MAJOR CLINICAL STUDY; P450 AROMATASE GENE; PROGESTERONE SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAR GENE; STEROIDOGENESIS; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; METABOLISM; OVARY; PHYSIOLOGY;

ACTIVINS; AROMATASE; CELLS, CULTURED; ENZYME ACTIVATION; ESTRADIOL; FEMALE; HUMANS; INHIBIN-BETA SUBUNITS; LUTEAL CELLS; OVARY; PHOSPHOPROTEINS; PROGESTERONE; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 84907665298     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1223     Document Type: Article

References (64)

1. Mather JP, Moore A, Li RH. Activins, inhibins, and follistatins: further thoughts on a growing family of regulators. Proc Soc Exp Biol Med. 1997;215:209-222.
2. De Paolo LV. Inhibins, activins, and follistatins: the saga continues. Proc Soc Exp Biol Med. 1997;214:328-339.
3. Houben H, Denef C. Bioactive peptides in anterior pituitary cells. Peptides. 1994;15:547-582.
4. Rabinovici J, Goldsmith PC, Roberts VJ, Vaughan J, Vale W, Jaffe RB. Localization and secretion of inhibin/activin subunits in the human and subhuman primate fetal gonads. J Clin Endocrinol Metab. 1991;73:1141-1149.
5. McNatty KP, Fidler AE, Juengel JL, et al. Growth and paracrine factors regulating follicular formation and cellular function. Mol Cell Endocrinol. 2000;163:11-20.
6. Drummond AE, Le MT, Ethier JF, Dyson M, Findlay JK. Expression and localization of activin receptors, Smads, and β glycan to the postnatal rat ovary. Endocrinology. 2002;143:1423-1433.
7. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. Alphainhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 1992;360:313-319.
8. Matzuk MM, Kumar TR, Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature. 1995;374:356-360.
9. Nishimori K, Matzuk MM. Transgenic mice in the analysis of reproductive development and function. Rev Reprod. 1996;1:203-212.
10. Rabinovici J, Spencer SJ, Doldi N, Goldsmith PC, Schwall R, Jaffe RB. Activin-A as an intraovarian modulator: actions, localization, and regulation of the intact dimer in human ovarian cells. J Clin Invest. 1992;89:1528-1536.
11. Stock AE, Woodruff TK, Smith LC. Effects of inhibin A and activin A during in vitro maturation of bovine oocytes in hormone- and serum-free medium. Biol Reprod. 1997;56:1559-1564.
12. Alak BM, Coskun S, Friedman CI, Kennard EA, Kim MH, Seifer DB. Activin A stimulates meiotic maturation of human oocytes and modulates granulosa cell steroidogenesis in vitro. Fertil Steril. 1998;70:1126-1130.
13. Rabinovici J, Spencer SJ, Jaffe RB. Recombinant human activin-A promotes proliferation of human luteinized preovulatory granulosa cells in vitro. J Clin Endocrinol Metab. 1990;71:1396-1398.
14. Hillier SG, Miró F. Inhibin, activin, and follistatin. Potential roles in ovarian physiology. Ann N Y Acad Sci. 1993;687:29-38.
15. Hutchinson LA, Findlay JK, de Vos FL, Robertson DM. Effects of bovine inhibin, transforming growth factor-β and bovine activin-A on granulosa cell differentiation. Biochem Biophys Res Commun. 1987;146:1405-1412.
16. Miró F, Smyth CD, Hillier SG. Development-related effects of recombinant activin on steroid synthesis in rat granulosa cells. Endocrinology. 1991;129:3388-3394.
17. Shukovski L, Findlay JK, Robertson DM. The effect of follicle-stimulating hormone-suppressing protein or follistatin on luteinizing bovine granulosa cells in vitro and its antagonistic effect on the action of activin. Endocrinology. 1991;129:3395-3402.
18. Myers M, van den Driesche S, McNeilly AS, Duncan WC. Activin A reduces luteinisation of human luteinised granulosa cells and has opposing effects to human chorionic gonadotropin in vitro. J Endocrinol. 2008;199:201-212.
19. Shi FT, Cheung AP, Klausen C, Huang HF, Leung PC. Growth differentiation factor 9 reverses activin A suppression of steroidogenic acute regulatory protein expression and progesterone production in human granulosa-lutein cells. J Clin Endocrinol Metab. 2010;95:E172-E180.
20. Li W, Yuen BH, Leung PC. Inhibition of progestin accumulation by activin-A in human granulosa cells. J Clin Endocrinol Metab. 1992;75:285-289.
21. Cataldo NA, Rabinovici J, Fujimoto VY, Jaffe RB. Follistatin antagonizes the effects of activin-A on steroidogenesis in human luteinizing granulosa cells. J Clin Endocrinol Metab. 1994;79:272-277.
22. Ying SY. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev. 1988;9:267-293.
23. Hotten G, Neidhardt H, Schneider C, Pohl J. Cloning of a new member of the TGF-β family: a putative new activin β C chain. Biochem Biophys Res Commun. 1995;206:608-613.
24. Hashimoto O, Tsuchida K, Ushiro Y, et al. cDNA cloning and expression of human activin βE subunit. Mol Cell Endocrinol. 2002;194:117-122.
25. Fang J, Yin W, Smiley E, Wang SQ, Bonadio J. Molecular cloning of the mouse activin β E subunit gene. Biochem Biophys Res Commun. 1996;228:669-674.
26. Mylonas I, Brüning A, Shabani N, Kunze S, Kupka MS.. Evidence of inhibin/activin subunit βC and βE synthesis in normal human endometrial tissue. Reprod Biol Endocrinol. 2010;8:143.
27. Mellor SL, Cranfield M, Ries R, et al. Localization of activin β (A)-, β (B)-, and β (C)-subunits in human prostate and evidence for formation of new activin heterodimers of β (C)-subunit. J Clin Endocrinol Metab. 2000;85:4851-4858.
28. Blankenstein T, Jückstock J, Shabani N, et al. Immunolabelling of the inhibin/activin-βC subunit in normal and malignant human uterine cervical tissue and cervical cancer cell lines. Oncol Rep. 2011;25:147-152.
29. Weissenbacher T, Brüning A, Kimmich T, Makovitzky J, Gingelmaier A, Mylonas I. Immunohistochemical labeling of the inhibin/activin βC subunit in normal human placental tissue and chorionic carcinoma cell lines. J Histochem Cytochem. 2010;58:751-757.
30. Gold EJ, O'Bryan MK, Mellor SL, et al. Cell-specific expression of βC-activin in the rat reproductive tract, adrenal and liver. Mol Cell Endocrinol. 2004;222:61-69.
31. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocr Rev. 2002;23:787-823.
32. Knight PG, Glister C. Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reproduction. 2001;121:503-512.
33. Knight PG, Satchell L, Glister C. Intra-ovarian roles of activins and inhibins. Mol Cell Endocrinol. 2012;359:53-65.
34. Brown CW, Houston-Hawkins DE, Woodruff TK, Matzuk MM. Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions. Nat Genet. 2000;25:453-457.
35. Chang HM, Klausen C, Leung PC. Antimüllerian hormone inhibits follicle-stimulating hormone-induced adenylyl cyclase activation, aromatase expression, and estradiol production in human granulosa-lutein cells. Fertil Steril. 2013;100:585-592.e1.
36. Wen X, Tozer AJ, Butler SA, Bell CM, Docherty SM, Iles RK. Follicular fluid levels of inhibin A, inhibin B, and activin A levels reflect changes in follicle size but are not independent markers of the oocyte's ability to fertilize. Fertil Steril. 2006;85:1723-1729.
37. Amsterdam A, Selvaraj N. Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes. Endocr Rev. 1997;18:435-461.
38. Nakao A, Imamura T, Souchelnytskyi S, et al. TGF-β receptormediated signalling through Smad2, Smad3 and Smad4. EMBO J. 1997;16:5353-5362.
39. Thompson TB, Cook RW, Chapman SC, Jardetzky TS, Woodruff TK. β A versus β B: is it merely a matter of expression? Mol Cell Endocrinol. 2004;225:9-17.
40. Vassalli A, Matzuk MM, Gardner HA, Lee KF, Jaenisch R. Activin/inhibin β B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev. 1994;8:414-427.
41. Roberts VJ, Barth S, el-Roeiy A, Yen SS. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab. 1993;77:1402-1410.
42. Glister C, Groome NP, Knight PG. Bovine follicle development is associated with divergent changes in activin-A, inhibin-A and follistatin and the relative abundance of different follistatin isoforms in follicular fluid. J Endocrinol. 2006;188:215-225.
43. Young JM, Henderson S, Souza C, Ludlow H, Groome N, McNeilly AS. Activin B is produced early in antral follicular development and suppresses thecal androgen production. Reproduction. 2012;143:637-650.
44. Evans LW, Muttukrishna S, Knight PG, Groome NP. Development, validation and application of a two-site enzyme-linked immunosorbent assay for activin-AB. J Endocrinol. 1997;153:221-230.
45. Ginther OJ, Beg MA, Bergfelt DR, Kot K. Activin A, estradiol, and free insulin-like growth factor I in follicular fluid preceding the experimental assumption of follicle dominance in cattle. Biol Reprod. 2002;67:14-19.
46. Muttukrishna S, Fowler PA, George L, Groome NP, Knight PG. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab. 1996;81:3328-3334.
47. Miró F, Hillier SG. Relative effects of activin and inhibin on steroid hormone synthesis in primate granulosa cells. J Clin Endocrinol Metab. 1992;75:1556-1561.
48. Massagué J. TGF-β signal transduction. Annu Rev Biochem. 1998;67:753-791.
49. Greenwald J, Groppe J, Gray P, et al. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol Cell. 2003;11:605-617.
50. Greenwald J, Fischer WH, Vale WW, Choe S. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase. Nat Struct Biol. 1999;6:18-22.
51. Mathews LS, Vale WW. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell. 1991;65:973-982.
52. Adkins HB, Bianco C, Schiffer SG, et al. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J Clin Invest. 2003;112:575-587.
53. Schneyer A, Schoen A, Quigg A, Sidis Y. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology. 2003;144:1671-1674.
54. Xiao S, Robertson DM, Findlay JK. Effects of activin and folliclestimulating hormone (FSH)-suppressing protein/follistatin on FSH receptors and differentiation of cultured rat granulosa cells. Endocrinology. 1992;131:1009-1016.
55. Shi FT, Cheung AP, Huang HF, Leung PC. Growth differentiation factor 9 (GDF9) suppresses follistatin and follistatin-like 3 production in human granulosa-lutein cells. PLoS One. 2011;6:e22866.
56. Schneyer AL, Rzucidlo DA, Sluss PM, Crowley WF Jr. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology 1994;135:667-674.
57. Shimonaka M, Inouye S, Shimasaki S, Ling N. Follistatin binds to both activin and inhibin through the common subunit. Endocrinology. 1991;128:3313-3315.
58. Thomas TZ, Chapman SM, Hong W, et al. Inhibins, activins, and follistatins: expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia. Prostate. 1998;34:34-43.
59. McPherson SJ, Thomas TZ, Wang H, Gurusinghe CJ, Risbridger GP. Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145. J Endocrinol. 1997;154:535-545.
60. Lau AL, Kumar TR, Nishimori K, Bonadio J, Matzuk MM. Activin βC and βE genes are not essential for mouse liver growth, differentiation, and regeneration. Mol Cell Biol. 2000;20:6127-6137.
61. Gold E, Jetly N, O'Bryan MK, et al. Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo. Am J Pathol. 2009;174:184-195.
62. Wada W, Maeshima A, Zhang YQ, Hasegawa Y, Kuwano H, Kojima I. Assessment of the function of the βC-subunit of activin in cultured hepatocytes. Am J Physiol Endocrinol Metab. 2004;287:E247-E254.
63. Vejda S, Erlach N, Peter B, et al. Expression of activins C and E induces apoptosis in human and rat hepatoma cells. Carcinogenesis. 2003;24:1801-1809.
64. Mellor SL, Ball EM, O'Connor AE, et al. Activin βC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate. Endocrinology. 2003;144:4410-4419.